miLab Platform – Transforming Global Diagnostics with AI

Noul’s miLab is a next-generation AI-powered diagnostic platform designed to deliver laboratory-grade accuracy directly at the point of care — without the need for large laboratory infrastructure or specialized personnel. By fully automating the entire microscopy diagnostic process — from sample preparation and high-resolution imaging to AI-based analysis — miLab generates precise blood and cancer diagnostic results within 15 minutes, dramatically improving speed, accessibility, and operational efficiency in both high-resource and resource-limited settings.

Unlike conventional diagnostic systems, miLab integrates hardware, bio-cartridge, and on-device AI technologies into a compact, cost-effective, and fully integrated solution. This unique convergence of technologies allows healthcare providers, diagnostic labs, and governments to scale diagnostic capacity faster and more efficiently across diverse environments.

miLab’s global validation is already well recognized:

• In 2022, Unitaid identified miLab as “the most advanced digital microscope and fully integrated bench-top platform”, positioning it as one of the advanced point-of-care hematology solutions globally.

• In 2024, the WHO-Unitaid report recommended Noul’s AI-powered cervical cytology solution (miLab CER) as one of the Top 3 triage tests for cervical cancer screening worldwide — alongside leading global players Roche and Hologic.

With strong clinical data, proven AI performance, and increasing regulatory approvals, miLab is rapidly expanding into global markets. Following its commercial success in malaria diagnostics, miLab's blood analysis and cancer cytology solutions are now used in 28 countries across pharmaceutical companies, healthcare systems, laboratories, and government agencies.

About Noul

Noul Co., Ltd. (KOSDAQ: 376930.KR) is an on-device AI healthcare company founded in 2015 with the mission: “Exploring human's most challenging healthcare problems to create new solutions and turn possibilities into reality.”

Leveraging deep expertise in AI, biomedical engineering, and edge-computing technologies, Noul has developed the world's first fully integrated AI-powered diagnostic lab-on-device platform.

Noul’s vision is to impact over 1 billion lives by improving global access to precision blood and cancer diagnostics, addressing unmet needs across both advanced and underserved healthcare systems.
Website: https://noul.com